Trial Site Detail

 

Drug:
Imatinib
Trial:
Five Year Adjuvant Imatinib Mesylate (GleevecĀ®) in Gastrointestinal Stromal Tumor (GIST) (Novartis CSTI571BUS282)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

South Texas Oncology Hematology

     
San Antonio , TX 78229
USA

 

Principal Investigator:
Ronald Drengler, MD
Contact:
Lacey Frank 210-593-5725
Activation Status of this Site:
Closed
Notes about this Site:
South Texas Oncology Hematology Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.